首页> 外文OA文献 >P685 Healthcare resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease

【2h】

P685 Healthcare resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease

机译：P685医疗保健资源用途与炎症性肠病患者的铁缺乏症和IV铁处理有关的氧缺乏症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S Howaldt; I Jacob; M Sampson; F Akriche;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study [J] . Schmidt C., Ahmad T., Tulassay Z., Alimentary pharmacology & therapeutics. . 2016,第3期

机译：麦芽酚铁治疗炎性肠病患者缺铁性贫血：3期研究的长期扩展数据
2. Ferric maltol in iron deficiency anaemia in patients with inflammatory bowel disease: a guide to its use [J] . Katherine A. Lyseng-Williamson Drugs & therapy perspectives: for rational drug selection and use . 2016,第6期

机译：麦芽酚铁在炎性肠病患者缺铁性贫血中的使用指南
3. Ferric maltol (ST10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease [J] . Expert opinion on pharmacotherapy . 2015,第18期

机译：麦芽酚铁（ST10）：一种新型口服铁补充剂，用于治疗炎症性肠病中的铁缺乏性贫血
4. Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases [C] . J.-F. COLOMBEL, M. TORUNE Falk Symposium . 2007

机译：炎症性肠病患者的发病率增加了与免疫调节治疗有关的发病危险
5. Treatment of Iron Deficiency in Pediatric Patients with Inflammatory Bowel Disease [D] . ?Spaan, Jonathan 2020

机译：炎症性肠病患者缺铁缺乏的治疗方法
6. Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK [O] . JR Fraser Cummings, Aileen Fraser, Catherine Stansfield, 2021

机译：麦芽酚现实世界效力研究在医院实践（新鲜）：英国铁缺乏症患者炎症性肠病患者的临床特征和结果
7. P331 Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: A comparison of ferric maltol and IV iron [O] . S Howaldt, I Jacob, M Sampson, 2020

机译：P331炎症性肠病患者的生产率丧失接受缺铁性贫血的治疗：麦芽酚和IV铁的比较

P685 Healthcare resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease

著录项

引文网络

相似文献

相关主题

期刊订阅